While Big Pharma seems ready to weather the tariff storm, independent pharmacists and makers of generic drugs — which account for 90% of U.S. prescriptions — see trouble ahead for patients.
Category: Health Industry
Trump Team’s $500 Million Bet on Old Vaccine Technology Puzzles Scientists
Secretary Robert F. Kennedy Jr.’s HHS said an enormous, noncompetitive flu vaccine development grant to two favored NIH leaders would ensure “transparency, effectiveness, and comprehensive preparedness.” But their vaccine is in early stages, relies on old technology, and is just one of scores of similar efforts.
California’s Primary Care Shortage Persists Despite Ambitious Moves To Close Gap
The state has in recent years embraced several initiatives recommended in an influential health care workforce report, including alternative payment arrangements for primary care doctors to earn more. Despite increasing residency programs, student debt forgiveness, and tuition-free medical school, California is unlikely to meet patient demand, observers say.